Cargando…

Evaluation of a Conservative Pharmacist-led U-500R Insulin Management Protocol in the Primary Care Setting

OBJECTIVE: The objective of this quality assurance study is to evaluate the impact of a conservative, pharmacist-led, U-500R insulin management protocol on diabetes control (A1c) and total daily dosage requirements between August 2016 and August 2018. METHODS: This was a retrospective chart review o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dumont, Cyndi, Fitzgerald, Leah, Valdez, Connie A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7682224/ https://www.ncbi.nlm.nih.gov/pubmed/33218271 http://dx.doi.org/10.1177/2150132720973827

Ejemplares similares

Development and Implementation of a U-500 Regular Insulin Program in a Federally Qualified Health Center
por: Shaw, Kathy F., et al.
Publicado: (2017)

Delayed Response to U-500 Regular Insulin
por: Davidson, Mayer B.
Publicado: (2018)

Implementation of pharmacist-led deprescribing in collaborative primary care settings
por: Trenaman, Shanna C., et al.
Publicado: (2022)

SAT167 Risk Of Life Threatening Hypoglycemia When Using U-100 Insulin Syringes To Administer R U-500 Insulin
por: Rizwan, Tehlil, et al.
Publicado: (2023)

MON-152 Less Is More: Human Regular U-500 Insulin
por: Lugo Lopez, Zahira, et al.
Publicado: (2019)

Insulin Edema With Use of U-500 Regular Insulin in a Hybrid Closed-Loop Insulin Pump
por: Vasigh, Mostafa, et al.
Publicado: (2020)

Advancing Patient Safety and Access to Concentrated Insulin (U-500 Regular Insulin) in the Veterans Health Administration: A Clinician Education Program in the Primary Care Setting
por: Lutz-McCain, Stacey J., et al.
Publicado: (2018)

Pharmacist-led antimicrobial stewardship program in an urgent care setting
por: Fay, Lauren N, et al.
Publicado: (2019)

LBSUN294 Insulin-induced Abdominal Acanthosis Nigricans From High Doses Of Insulin U-500
por: Yap, Sara Elizabeth, et al.
Publicado: (2022)

FRI654 Concentrated Regular U-500 Insulin In An Automated Insulin Delivery System: A Case Report
por: Aurora, John, et al.
Publicado: (2023)

Pharmacokinetics and Pharmacodynamics of High-Dose Human Regular U-500 Insulin Versus Human Regular U-100 Insulin in Healthy Obese Subjects
por: de la Peña, Amparo, et al.
Publicado: (2011)

Exploring patient willingness to pay for pharmacist-led clinical services in a primary care setting
por: Park, Jamie Y., et al.
Publicado: (2022)

The Impact of a Pharmacist-led Warfarin Educational Video in a Saudi Setting
por: Shilbayeh, Sireen Abdul Rahim
Publicado: (2020)

Evaluating the Effect of U-500 Insulin Therapy on Glycemic Control in Veterans With Type 2 Diabetes
por: Granata, Joseph A., et al.
Publicado: (2015)

U-500 Regular Insulin: Clinical experience and pharmacokinetics in obese, severely insulin-resistant type 2 diabetic patients
por: Davidson, Mayer B., et al.
Publicado: (2010)

SAT-LB028 Efficacy and Safety of Pramlintide as an Adjunct to Insulin U500 Therapy in Veterans with Severe Insulin Resistance
por: Oprea, Mihaela, et al.
Publicado: (2019)

U500 Disposable Patch Insulin Pump: Results and Discussion of a Veterans Affairs Pilot Study
por: Martin, Christopher, et al.
Publicado: (2018)

Duration and onset of action of high dose U‐500 regular insulin in severely insulin resistant subjects with type 2 diabetes
por: Shrestha, Rupendra T., et al.
Publicado: (2018)

Interventions for improving pharmacist-led patient counselling in the community setting: a systematic review
por: Al Aqeel, Sinaa, et al.
Publicado: (2018)

Translating U-500R Randomized Clinical Trial Evidence to the Practice Setting: A Diabetes Educator/Expert Prescriber Team Approach
por: Bergen, Paula M., et al.
Publicado: (2017)

AbobotulinumtoxinA provides flexibility for the treatment of cervical dystonia with 500 U/1 mL and 500 U/2 mL dilutions
por: Lew, Mark F., et al.
Publicado: (2021)

Effects of Pharmacist-Led Clinical Pathway/Order Sets on Cancer Patients: A Systematic Review
por: Tan, Zhiyuan, et al.
Publicado: (2021)

A Guide to a Pharmacist-Led Pharmacogenetic Testing and Counselling Service in an Interprofessional Healthcare Setting
por: Stäuble, Céline K., et al.
Publicado: (2022)

Treatment Patterns and Outcomes Before and After Humulin R U-500 Initiation Among US Patients with Type 2 Diabetes Previously Prescribed ≤ 200 Units/day of U-100 Insulin
por: Chen, Jieling, et al.
Publicado: (2022)

Pharmacists as Personalized Medicine Experts (PRIME): Experiences Implementing Pharmacist-Led Pharmacogenomic Testing in Primary Care Practices
por: Luke, Miles J., et al.
Publicado: (2021)

A pharmacist-led medication switch protocol in an academic HIV clinic: patient knowledge and satisfaction
por: Lee, Sarah S., et al.
Publicado: (2018)

Effect of pharmacist-led intervention protocol on preventing postoperative delirium after elective cardiovascular surgery
por: Asai, Yuki, et al.
Publicado: (2023)

Impact of pharmacist-led medication management in care transitions
por: Yang, Seungwon
Publicado: (2017)

Principles of pharmacoeconomic analysis: the case of pharmacist-led interventions
por: Tonin, Fernanda S., et al.
Publicado: (2021)

Patient-reported outcomes in transition from high-dose U-100 insulin to human regular U-500 insulin in severely insulin-resistant patients with type 2 diabetes: analysis of a randomized clinical trial
por: Kabul, Samaneh, et al.
Publicado: (2016)

Cost utility of a pharmacist-led minor ailment service compared with usual pharmacist care
por: Dineen-Griffin, Sarah, et al.
Publicado: (2020)

The impact of community–pharmacist-led medication reconciliation process: Pharmacist-patient-centered medication reconciliation
por: AlAhmad, Mohammad M, et al.
Publicado: (2020)

Glycemic Control and Management in Pharmacist-Led Diabetic Clinic vs. Physician-Led Diabetic Clinic
por: Alghadeer, Sultan M., et al.
Publicado: (2021)

A Pharmacist-Led Point-of-Care INR Clinic: Optimizing Care in a Family Health Team Setting
por: Rossiter, Jennifer, et al.
Publicado: (2013)

Setting Goals to Reduce Cardiovascular Risk: A Retrospective Chart Review of a Pharmacist-Led Initiative in the Workplace
por: Klaassen, Alicia E., et al.
Publicado: (2023)

Evaluating the potential outcomes of pharmacist-led activities in the Australian general practice setting: a prospective observational study
por: Sudeshika, Thilini, et al.
Publicado: (2023)

Human regular U‐500 insulin via continuous subcutaneous insulin infusion versus multiple daily injections in adults with type 2 diabetes: The VIVID study
por: Grunberger, George, et al.
Publicado: (2020)

Pharmacist-led minor ailment programs: a Canadian perspective
por: Taylor, Jeff Gordon, et al.
Publicado: (2016)

Pharmacist-led medication-related needs assessment in rural Ghana
por: Wilby, Kyle John, et al.
Publicado: (2013)

Pharmacist-led screening in sexually transmitted infections: current perspectives
por: Wood, Helen, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_e9r3qkh63bm6c9855c9ftnnfhk